For instance, the SE1 monoclonal antibody prevents the binding of SHH to PTC1 [50], but the effectiveness of this and other anti-SHH antibodies against BC has so far been proven only preclinically [21,51,52]. This evidence concerns the gene SHH and breast cancer.